Fact-checked by Grok 2 weeks ago

Biohackers

Biohackers are individuals who engage in do-it-yourself biological experimentation, primarily on themselves, to enhance human physical, cognitive, and capabilities through targeted interventions such as optimizations, pharmacological agents, biometric monitoring, and biotechnological modifications. The practice draws from principles of and self-quantification, often bypassing conventional medical oversight in favor of iterative personal testing to identify causal improvements in metrics like metabolic efficiency or neural function. Emerging in the late 2000s amid accessible genetic tools and online communities, biohacking formalized as "DIY biology" around 2008, evolving from earlier garage experimentation into structured efforts like community labs and open-source protocols. Common methods include nutraceutical regimens (e.g., nootropics for focus), circadian-aligned routines (e.g., and tracking), environmental stressors (e.g., cold therapy for resilience), and advanced hacks like subcutaneous implants for logging or amateur therapies for augmentation. Proponents cite anecdotal and preliminary showing gains in and , such as reduced from ketogenic protocols or heightened from quantified , though large-scale randomized trials remain sparse due to the decentralized nature of the field. Notable figures include self-experimenters pioneering extreme protocols, like plasma exchanges for rejuvenation, which have popularized quantified self-tracking via wearables but also highlighted variability in outcomes. The movement's defining characteristics—empirical tinkering and rejection of institutional gatekeeping—have spurred innovations in accessible tech, such as consumer kits, yet provoke controversies over unverified efficacy and hazards like from implants or unintended genetic off-target effects, which regulatory analyses deem inevitable without oversight. risks extend to ecological threats from self-replicating constructs, underscoring tensions between individual liberty and collective precaution in an era of democratized biotech. Despite hype in circles, rigorous favors modest, low-risk hacks like exercise dosing over speculative interventions, aligning with causal mechanisms rooted in metabolic and neuroplastic adaptations.

Premise

Synopsis


is a television series created by . The series premiered on on , 2020, and consists of two seasons, with the second released on July 9, 2021. It centers on the intersection of advanced , personal vendettas, and ethical dilemmas in genetic research.
The narrative follows Akerlund, a driven medical student who enrolls at a top on a covert mission to expose Tanja Lorenz, a pioneering geneticist implicated in a family tragedy involving Mia's twin brother. Posing as an ordinary freshman, Mia infiltrates Lorenz's inner circle, forging alliances with biohacking enthusiasts like Jasper, a biology prodigy experimenting with gene therapies for personal ailments, and others pushing boundaries in synthetic biology and human augmentation. As Mia delves deeper, she encounters clandestine experiments involving CRISPR-like editing, implantable devices for sensory enhancement, and chimeric organisms, revealing a shadowy network of scientific ambition unchecked by regulation. The series portrays not merely as hobbyist tinkering but as a potent force capable of reshaping human capabilities, fraught with risks of and unintended mutations. Themes of intertwine with explorations of and the moral costs of technological , set against the university's high-stakes academic milieu.

Cast and Characters

Main Characters

Mia Akerlund, portrayed by , serves as the protagonist, a talented and driven medical student who arrives at the under an assumed identity to infiltrate the lab of Professor Tanja Lorenz amid suspicions tied to her brother's death. Her pursuit involves navigating ethical dilemmas in while forming alliances with peers involved in advanced genetic experimentation. Professor Tanja Lorenz, played by , is a pioneering and head of her own institute, renowned for groundbreaking work in gene splicing and aimed at treating genetic disorders. Her research pushes boundaries in and , positioning her as a central figure in the series' exploration of bioethical frontiers. Jasper, portrayed by Adrian Julius Tillmann, acts as Lorenz's and a brilliant young managing a personal biohackspace where he develops experimental gene therapies for his own rare genetic condition, . Despite apparent disinterest in lectures, his expertise drives key plot elements involving illicit genetic modifications. Niklas, played by Thomas Prenn, is Jasper's brooding roommate and a enthusiast whose eccentric involvement in underground tech experiments intersects with Mia's investigation, evolving into a pivotal role across the narrative. His includes early encounters with that hint at deeper connections to the university's secretive genetic projects.

Recurring Characters

Lotta, portrayed by , serves as Akerlund's roommate and a fellow medical student at the university, characterized by her outgoing and uninhibited personality, often engaging in social activities and providing amid the series' tense plot. She appears across multiple episodes in both seasons, interacting with the core group and occasionally aiding in informal investigations, though her role remains peripheral to the central genetic conspiracy. Chen-Lu, played by Jing Xiang, is a skilled biohacker and member of the student circle involved in experimental genetic work, contributing technical expertise in gene editing and surveillance techniques during key plot developments. Her appearances span several episodes, particularly in scenes involving underground lab activities and ethical dilemmas surrounding , highlighting the risks of unregulated experimentation. Other recurring figures include , enacted by Sebastian Jakob Doppelbauer, a competitive who clashes with protagonists over academic and personal rivalries, appearing in confrontational sequences that underscore dynamics. Additionally, supporting academics like professors and assistants recur in advisory or obstructive capacities, such as those overseeing university protocols, but their individual impacts are less pronounced than the student ensemble. These characters collectively amplify the narrative's exploration of subcultures without driving the primary intrigue.

Production

Development and Writing

Biohackers was conceived by German director , who developed the core concept after consulting scientists on the ethical dilemmas in that most concerned them, including advancements in gene editing and . Ditter aimed to create a positioned "five minutes into the future," grounding speculative elements in plausible near-term scientific progress to explore moral boundaries in and genetic manipulation. As creator, , writer, and , Ditter led the , collaborating with Tim Trachte to script the series' fast-paced structure, which centers on a medical student's investigation into conspiracies at a prestigious . The scripts emphasize intrigue over rigorous scientific exposition, prioritizing plot twists and character-driven ethical conflicts, though critics have noted occasional superficiality in handling complex biotech themes. Development progressed rapidly, with greenlighting a second season just one week after the August 20, 2020 premiere, reflecting confidence in the writing's commercial appeal.

Casting

Daniela Tolkien served as the casting director for both seasons of Biohackers, responsible for selecting the principal and supporting actors. Principal casting occurred prior to filming, which began in June 2019, with Swiss actress selected for the lead role of Mia Akerlund/Emma Engels, drawing on her prior performance in the 2017 film Blue My Mind. German actress was cast as the antagonist Tanja Lorenz, leveraging her experience in roles requiring intellectual intensity. Supporting roles included Thomas Prenn as Niklas, Adrian Julius Tillmann as Jasper, and as Lotta, announced alongside the leads in mid-2020 Netflix press releases confirming the ensemble's alignment with the series' youth-driven tone. Creator and director , involved in final approvals, praised the cast's chemistry in reflections, emphasizing their ability to convey the high-stakes bioethical drama. For 2, the core cast returned, supplemented by additions like , with Tolkien again handling selections to maintain continuity amid expanded plotting. No public details emerged on open calls versus targeted auditions, though Tolkien's prior work on German productions like Fack ju Göhte suggests a focus on emerging talents suited to genre demands.

Filming and Technical Aspects

Principal photography for the first season of Biohackers commenced in July 2019, with scenes shot at the Albert-Ludwigs-Universität Freiburg to depict the university setting, while the majority of interior and studio work occurred in . Additional exteriors were filmed in , , and at Bavaria Filmstadt in to capture the series' academic and laboratory environments. The production adhered closely to the story's Freiburg backdrop for authenticity in educational scenes but relied on controlled studio conditions in for complex biohacking sequences involving and genetic modification visuals. Cinematography was handled by directors of photography Jakob Wiessner and Fabian Rösler, whose work emphasized visually striking compositions that enhanced the thriller's tense atmosphere, particularly in and nocturnal settings. technician Helmut Neudorfer contributed to practical elements, such as rigging for dynamic shots, while compositing was led by Visual Effects Studios to integrate digital enhancements for depictions and microscopic biological processes. Editing featured sharp, glossy cuts with effective use of flashbacks to reveal layers, supporting the series' high values in pacing technical and ethical intrigue. These aspects collectively prioritized realism in scientific portrayals, drawing from actual university facilities while employing techniques to simulate advanced biotech without compromising factual grounding in gene-editing concepts like .

Episodes

Season 1 (2020)

Season 1 of Biohackers consists of six episodes, all released simultaneously on on August 20, 2020. The episodes were directed by for the first three and Tim Trachte for the last three, with writing credited to series creator .
No.TitleDirected byOriginal release date
1ArrivalAugust 20, 2020
2SecretsAugust 20, 2020
3SuspicionAugust 20, 2020
4CertaintyTim TrachteAugust 20, 2020
5BetrayalTim TrachteAugust 20, 2020
6FateTim TrachteAugust 20, 2020
  • "Arrival": After meeting her unconventional roommates, attends her first class with Dr. Lorenz and cozies up to the professor's , .
  • "Secrets": tries to wheedle her way into a job at Dr. Lorenz's biomedical institute but runs into a problem when she's asked to participate in a genetic .
  • "Suspicion": 's night out with leads to Dr. Lorenz's private residence, where a complicates her plans to access the professor's computer.
  • "Certainty": Dr. Lorenz's growing suspicions cause to question his relationship with , who finds a new confidante in her desperate search for answers.
  • "Betrayal": As makes a last-ditch effort to obtain proof about Dr. Lorenz's experiments, begins to unravel over his feelings of .
  • "Fate": On the run and with time running out, turns to her for help in a life-and-death race to save the train's passengers.

Season 2 (2021)

The second season of , comprising six episodes, was released worldwide on on July 9, 2021. returned as and head writer, directing the first two episodes, while Tim Trachte directed episodes three through six. The season advances the narrative from Akerlund's abduction at the close of season one, depicting her awakening with spanning the prior three months and her subsequent pursuit of concealed biohacking procedures tied to Professor Lorenz's research. The storyline centers on decoding encrypted messages from her former self, navigating alliances and betrayals amid experiments involving genetic editing and neural manipulation, culminating in revelations about familial secrets and ethical breaches in . New elements introduce advanced applications for memory alteration and , building on the series' examination of unregulated genetic technologies.

Episode list

No. overallNo. in seasonTitle (German/English)Directed byOriginal release date
71"Aufwachen" / "Awake",
82"Feinde" / "Enemies",
93"Partner" / "Partners"Tim Trachte,
104"Vergessen" / "Forgotten"Tim Trachte,
115"Finden" / "Found"Tim Trachte,
126"Kämpfen" / "Fight"Tim Trachte,

Release and Distribution

Premiere and Platforms

Biohackers premiered globally on with its first season on August 20, 2020, releasing all six episodes simultaneously as is standard for Netflix Original series. The second and final season launched on on July 9, 2021, also comprising six episodes available worldwide from the outset. As a Netflix Original production, Biohackers streams exclusively on the Netflix platform, with no distribution on other major services or traditional television networks at launch or subsequently.

International Reach

Biohackers, a German-language Netflix original series, premiered globally on August 20, 2020, making both seasons available to subscribers in over 190 countries through Netflix's international distribution network. The second season followed with a worldwide release on July 9, 2021, maintaining simultaneous accessibility across regions without territorial broadcasting restrictions typical of traditional television. To broaden its appeal beyond German-speaking audiences, the series offers audio dubs in English, (Latin America), , and , alongside the original German track with options. are provided in numerous languages, including , (Simplified and Traditional), English, (Latin America), , , and others, enabling non-German speakers in diverse markets to engage with the content. Critics have noted that while English dubbing exists, viewing with preserves the original performances' nuances. The series' international footprint is evidenced by its inclusion in global recommendations for foreign-language sci-fi programming, contributing to Netflix's strategy of exporting European content to build viewership in , Asia, and . Despite lacking publicly disclosed country-specific viewership metrics from , audience engagement is reflected in aggregated user ratings from international platforms, such as IMDb's 6.8/10 score derived from over 12,000 global votes as of recent data.

Reception and Analysis

Critical Reviews

Biohackers garnered mixed to positive critical reception, with praise centered on its brisk pacing, twist-filled plotting, and exploration of , though detractors highlighted narrative inconsistencies and a orientation. The first season achieved a 100% Tomatometer score on from five critic reviews, reflecting acclaim for its dynamics and lead performance by as Mia Akerlund. Audience scores on the same platform averaged 73%, indicating broader viewer polarization. Critics lauded the series' ability to blend speculative with , as noted its "many twists and unexpected turns" that sustain engagement through a finale, positioning it as an unexpected standout in German originals. Decider highlighted the debut episode's tonal shifts from lighthearted to creepy, crediting Wedler's anchoring role for unifying the genre elements. awarded four stars, appreciating the "promising" sci-fi thriller framework while cautioning on depictions of substance use and ethical ambiguities in genetic manipulation. Conversely, some assessments pointed to structural flaws, including underdeveloped and reliance on tropes. Cineuropa argued that, despite a solid premise involving advanced biotech conspiracies, the narrative lacks unity, risking viewer confusion amid rapid plot shifts. Monsters and Critics observed an unanticipated " feel," with emphasis on teen romances overshadowing the scientific intrigue, diverging from expectations for a . Season 2 reviews maintained enthusiasm for amplified stakes, such as memory alteration and human augmentation, but with tempered scores. Ready Steady Cut rated it 3.5 of 5 stars, valuing its deepened inquiry into bodily resilience and modification costs, though execution remained thriller-prioritizing over scientific rigor. affirmed its "exciting, fast-paced" continuation, emphasizing Wedler's evolving portrayal amid escalating conspiracies. Old Ain't Dead deemed it "excellent and fascinating," particularly for resolving prior ambiguities while probing synthetic biology's frontiers. Overall, the limited critic sample—typical for non-English streaming imports—suggests scores may overstate , with aggregating user ratings at 6.8/10 from over 12,000 votes, underscoring entertainment value amid perceived clichés.

Audience and Commercial Performance

Biohackers achieved moderate audience engagement, reflected in its IMDb user rating of 6.8 out of 10, derived from 12,237 votes as of recent data. The series' Rotten Tomatoes audience score stands at 73%, indicating a generally favorable but not exceptional response from viewers, contrasted with a 100% critics' score based on a limited sample of five reviews. Demand metrics from Parrot Analytics show audience interest in the at 0.5 times the average for TV series, with similarly subdued levels in markets like at 0.2 times average, underscoring its niche appeal within Netflix's global catalog. Commercially, the series demonstrated initial viability through Netflix's rapid renewal for a second , announced on August 27, 2020—just one week after the August 20 premiere of season one—attributed to positive early viewer response. Season two followed on July 9, 2021, confirming short-term success for the production in attracting subscribers to Netflix's international originals slate. However, the absence of further seasons points to insufficient sustained performance to justify additional investment, aligning with Netflix's data-driven content decisions amid its expansive output of . Specific viewership figures remain undisclosed, consistent with Netflix's selective transparency on metrics prior to 2023 policy shifts.

Themes and Ethical Depictions

The Biohackers series intertwines themes of with personal revenge and academic intrigue, portraying as both an empowering tool for innovation and a pathway to unchecked ambition. Central to the narrative is the accessibility of , depicted through DIY experiments like creating mice and gene-modified plants, which highlight the democratization of via affordable tools and online resources. These elements underscore a tension between professional, secretive lab research—often tied to corporate pharmaceuticals—and informal biohacker communities operating in makeshift spaces, such as camper vans or home labs. Ethical depictions in the series emphasize the perils of bypassing institutional oversight in scientific pursuits, particularly in human experimentation and genetic modification. Professor Lorenz's unauthorized trials, including illicit gene therapies on stem cells and the creation of secret DNA databases from non-consensual samples like mouth swabs, illustrate violations of privacy and informed consent. The show critiques the hubris of altering human genomes without ethics committee approval, portraying such actions as driven by egotism and revenge rather than altruistic advancement, which risks unintended consequences like species-level disruptions or personal harm. Access to advanced therapies emerges as a key moral dilemma, contrasting exorbitant corporate treatments for rare genetic diseases with DIY solutions that evade regulatory barriers but expose individuals to untested risks. Characters grapple with the boundaries of scientific ambition, questioning the extent to which researchers can pursue breakthroughs—such as chimeric organisms or enhanced human capabilities—under the guise of progress, often prioritizing personal vendettas over societal safeguards. These portrayals reflect broader debates on genomic data misuse and the ethical imperatives of in an era of rapid biotechnological with AI-driven .

Accuracy and Influence on Biohacking Perceptions

The Netflix series Biohackers incorporates elements of real biotechnology, such as CRISPR-Cas9 gene editing for precise DNA modifications and synthetic biology techniques for engineering organisms, which have been demonstrated in laboratories since the mid-2010s. However, it compresses experimental timelines dramatically, portraying multi-day genetic sequencing and editing processes as achievable in minutes, which exceeds current laboratory capabilities even in well-equipped settings. Specific depictions, like instant see-in-the-dark vision via eye drops or rapid creation of glow-in-the-dark mice, draw from foundational research—such as optogenetic studies in rodents since 2005—but exaggerate feasibility and speed, blending established tools like pipettes, agarose gels for DNA visualization, and genomics software with fictional immediacy. Consultants from firms like Smartlab Architects ensured realistic lab designs and DIY biohacking spaces, including near-field communication (NFC) microchip implants for payments, which have been performed in humans since 2015, but the series overlooks regulatory barriers and failure rates inherent in such protocols. Critics with expertise in note that while basic procedures reflect authentic research workflows—including protocol failures and iterative testing—the narrative prioritizes thriller elements over precision, such as rogue genetic experiments yielding predictable behavioral outcomes like enhanced underwater breathing, which remain speculative and unverified . The portrayal of genomic data predicting facial structure with is overstated, as polygenic traits involve complex interactions not fully resolvable by current sequencing alone. Synthetic Elsa Sotiriadis, in a , praised the inclusion of multi-step ethical quandaries like in but critiqued the show's simplification of access to advanced tools, which in reality face stringent regulations under frameworks like Germany's Gene Technology Act. The series has shaped public perceptions of biohacking by framing it primarily as clandestine, high-stakes in underground labs, diverging from the broader, often less dramatic real-world practices like supplementation or basic implant experimentation conducted by communities since the early . This dramatized lens, evident in its 2020 premiere amid rising interest in following clinical trials like those for in 2019, amplifies associations with ethical risks—such as unauthorized human experimentation—potentially heightening public apprehension toward legitimate advancements, as noted in analyses blending the show's fiction with ongoing debates over DIY . Reviews indicate it sparks discourse on privacy in genomic data and equitable access to therapies but risks conflating institutional overreach with grassroots innovation, influencing viewers to view biohacking more as a peril-laden frontier than a democratizing pursuit.